Alternative or Better Approach Posterior Lumbar Motion Preservation Surgery

    0
    322

    The recent announcement of the first posterior total disc arthroplasty in the lumbar spine is sure to shift attention from the anterior lumbar approach for motion preservation to the posterior approach.

    In March, a posterior lumbar disc replacement device, the Secure-P (recently renamed Triumph Lumbar Disc, Globus Medical Inc.) was implanted in a 47-year-old woman with chronic degenerative disc disease at L4-L5. The two-piece implant is made of cobalt chrome and ultra-high-molecular-weight polyethylene. The device was implanted after a standard posterior approach and lumbar decompression.

    The interview on the next page with Paul McAfee, MD, who participated in the surgery in São Paulo, Brazil, addresses several questions about this type of surgery.

    Posterior total disc arthroplasty adds to the growing body of posterior solutions for achieving the goal of lumbar motion preservation, segmental load sharing and effective axial pain relief in those patients who traditionally would be treated with segmental fusions. Competing concepts include preservation of the annulus with nucleus replacements, and lumbar facet replacement technology.

    Preservation of the Annulus With Nucleus Replacements
    This category includes hydrogels, polycarbonate coiling spirals and metallic devices. Case series of hydrogel implants such as the PDN device (Prosthetic Disc Nucleus, Raymedica) have been reported. A polymer device designed to replace the nucleus in single-level lumbar spine degenerative disc disease (DASCOR Disc Arthroplasty System, Disc Dynamics) is currently in a prospective, multicenter pilot study. A spherical implant available in cobalt chromium or PEEK-Optima polymer (Satellite Spinal System, Medtronic Sofamor Danek) is cleared for use in the United States based on a 510(k) exemption, and its safety and efficacy have not yet been established by prospective, randomized trial data.

    Lumbar Facet Replacement Technology
    This category includes pedicle screw based implants such as TOPS (Impliant Ltd.), which contains two articulating titanium components connected by a polycarbonate urethane sleeve. The device constrains segmental motion to the neutral zone and thus maintains normative segmental load displacement, presumably diminishing segmental pain generation. TOPS currently is being subjected to a multicenter, double-armed, randomized trial in the United States, and it was approved by the European Commission this summer for use as a motion-preserving alternative to fusion in the treatment of spinal stenosis with or without degenerative facet arthrosis, and spondylolisthesis.

    Total Facet Arthroplasty System (Archus Orthopedics) is conceptually similar to the TOPS system. It is based on a pedicle fixation design and constrains segmental motion. In this system, however, pedicle fixation is accomplished with polymethylmethacrylate, PMMA, cement. A prospective randomized trial is currently enrolling patients in more than 20 centers.

    Dynamic Stabilization Systems
    Dynamic stabilization systems are becoming increasingly available and compete in the same market as the above devices by constraining segmental motion at abnormal, pain generating spinal segments rather than using traditional rigid fixation and segmental arthrodesis. These systems include the Graf ligament, Dynesys Dynamic Stabilization System (Zimmer Spine), Isobar TTL (Scient’x), and Stabilimax NZ Dynamic Spine Stabilization System (Applied Spine Technologies).

    Despite the resources being devoted to the development of posterior lumbar motion preservation technology and its clinical trials, it remains uncertain whether this is just an alternative to the standard segmental lumbar fusion with similar patient clinical outcomes or whether this is a superior approach to the treatment of segmental lumbar disease by virtue of motion preservation. In large part this answer depends on two factors:

    • whether the premature failure of a motion segment adjacent to a fusion is a consequence of rigid arthrodesis or if it represents the natural history of lumbar degenerative disease; and
    • whether the natural history of premature adjacent motion segment failure, regardless of etiology, is corrected by motion preservation surgery.

    Patrick W. McCormick, MD, FACS, MBA, is a partner in Neurosurgical Network Inc., Toledo, Ohio. He is associate editor of AANS Neurosurgeon.The author reported no conflicts for disclosure.

    A Surgeon’s Experience With Posterior Total Disc Arthroplasty

    In this interview, Patrick McCormick, MD, questions Paul McAfee, MD, a surgeon who participated in the first posterior total disc arthroplasty in the lumbar spine using the Secure-P device. Dr. McAfee is a consultant with and receives research funding from Globus Medical Inc.

    What is the degree of difficulty in placing the implant? Is it comparable to the time and effort required for a posterior lumbar interbody fusion with fixation?
    Dr. McAfee: It is actually easier. One requires good anteroposterior and lateral fluoroscopy because the final position of the implant needs to be accurately placed in the center of rotation for the motion segment. The other requirement is that the disc can be restored to normal height to get the full range of motion. On only our second case in Brazil, Luiz Pimenta was able to insert the posterior TLIF [transforaminal lumbar interbody fusion] disc replacement through a minimally invasive approach.

    Are precise positioning and sizing of the implant critical to the success of the surgery, or is the implant designed to be more forgiving in this regard?
    Dr. McAfee: It is about as forgiving as any other total disc replacement with a floating center of rotation. It would be best to get it within 3 mm of the ideal axis in both anteroposterior and lateral planes. Most surgeons should be able to accomplish this 95 percent of the time.

    How does this implant stack up against the anterior lumbar disc prostheses that are currently approved or under trial in the United States?
    Dr. McAfee: This is the most interesting of all of the newest, cutting-edge technologies that were presented at Robin Young’s course at the Spine Arthroplasty Society meeting in Berlin. Of all of Globus’ new products, this is the one that most surgeons inquire about because we are all more familiar and comfortable with posterior and posterolateral approaches, away from the friable great veins from the front to the spine.

    What additional insights and thoughts do you have regarding the prospects for a posterior total disc replacement system becoming a routine option for surgical treatment of lumbar disc disease?
    Dr. McAfee: In my experience the best preview we can really get is to see how well the device takes off in Europe. It will take three to five years to gain FDA IDE-PMA [investigational device exemption-premarket approval] in the United States. In this sorting-out period the spine community can get a preview of how well the prosthesis will perform in the general spine surgeon’s hands by seeing how rapid the adoption is in European spine centers in the next three years. As an example, look at how the Bryan cervical disc replacement faded in use in Europe-the lower profile cervical total disc replacement, which did not require a stereotactic frame, rapidly replaced the Bryan in Europe. The lower profile prostheses such as the ProDisc-C [Synthes], PCM [Porous Coated Motion, Cervitech Inc.], and Prestige-LP [Medtronic] took off, whereas the Bryan languished due to its complex instrumentation and the fact that it was not amenable to multiple-level application. This all sorted out in Europe before these devices were formally approved by the FDA for use in the United States.

    ]]>

    + posts